Table 1 Demographics
Patient and injury characteristics | |
|---|---|
Age, years – median (Q1; Q3) | 46 (31; 59) |
Male sex | 75% |
Penetrating trauma | 7% |
Traumatic brain injury | 55% |
AIS Head & Neck – median (Q1; Q3) | 3 (0; 4) |
AIS Face – median (Q1; Q3) | 0 (0; 1) |
AIS Thorax – median (Q1; Q3) | 3 (0; 4) |
AIS Abdomen – median (Q1; Q3) | 0 (0; 2) |
AIS Extremity – median (Q1; Q3) | 2 (0; 3) |
AIS External – median (Q1; Q3) | 0 (0; 0) |
ISS – median (Q1; Q3) | 25 (20; 34) |
Admission characteristics | |
Heart rate, bpm – median (Q1; Q3) | 90 (75; 110) |
SBP, mmHg – median (Q1; Q3) | 124 (96; 145) |
GCS – median (Q1; Q3) | 13 (6; 15) |
Hemoglobin (g/L) – median (Q1; Q3) | 13.4 (12.1; 14.5) |
Platelet count (109/L) – median (Q1; Q3) | 217 (173; 260) |
INR – median (Q1; Q3) | 1.1 (1; 1.2) |
APTT, s – median (Q1; Q3) | 26 (23; 32) |
Lactate, mmol/L – median (Q1; Q3) | 2.2 (1.4; 3.9) |
BE, mEq/L – median (Q1; Q3) | -3.4 (-7.2; -1) |
Syndecan-1, ng/mL – median (Q1; Q3) | 37 (21; 90) |
sTM, ng/mL – median (Q1; Q3) | 3.0 (1.9; 4.1) |
Adrenaline, pg/mL – median (Q1; Q3) | 201 (79; 356) |
sE-selectin– median (IQR) | 63 (46 – 89) |
sVE-cadherin – median (IQR) | 6.0 (3.6 – 8.5) |
Transfusions at 12 h* | |
Transfused (1 + units) – median (Q1; Q3) | 44% |
Major hemorrhage (4 + units) – median (Q1; Q3) | 31% |
Massive hemorrhage (20 + units) – median (Q1; Q3) | 11% |
Outcome | |
Ventilator days at 28d – median (Q1; Q3) | 1 (0; 5) |
Vasopressor days at 28d – median (Q1; Q3) | 0 (0; 2) |
RRT days at 28d – median (Q1; Q3) | 0 (0; 0) |
VTE | 5% |
SOFA score at 24 h – median (Q1; Q3) | 8 (4; 10) |
ICU LOS – median (Q1; Q3) | 3 (1; 8) |
Hospital LOS – median (Q1; Q3) | 11 (5; 24) |
ICU-free days at 28d – median (Q1; Q3) | 22 (4; 27) |
Hospital-free days at 28d – median (Q1; Q3) | 7 (0; 19) |
24 h mortality | 11% |
28d mortality | 21% |